Sponsor:
Case Comprehensive Cancer Center
Code:
NCT06687603
Conditions
Barrett Esophagus
Gastroesophageal Reflux
Esophageal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Interventions
EsoCheck
EsoGuard
Brief summary:
Conditions
Barrett Esophagus
Gastroesophageal Reflux
Esophageal Adenocarcinoma
Study ID
NCT06687603
Start date
Mar 10, 2025
Status verified date
Sep, 2026
Completion date
Sep 27, 2029
Anticipated
Primary completion date
Sep 27, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Accepted
Enrollment
800 participants
Anticipated
Intervention Model
Single group
Primary purpose
Prevention
Arms
experimental: EsoCheck + EsoGuard
Interventions
EsoCheck
EsoGuard
Primary outcome measure
Central contacts
Locations
University of Colorado
Recruiting
Aurora, Colorado, United States, 80045
Principal Investigator:
Sachin Wani, MD
Johns Hopkins Hospital
Recruiting
Baltimore, Maryland, United States, 21287
Principal Investigator:
Marcia Canto, MD
University of North Carolina at Chapel Hill
Recruiting
Chapel Hill, North Carolina, United States, 027599
Principal Investigator:
Nicholas Shaheen, MD
University Hospitals Cleveland Medical Center
Recruiting
Cleveland, Ohio, United States, 44016
Principal Investigator:
Amitabh Chak, MD
Cleveland Clinic Taussig Cancer Center
Recruiting
Cleveland, Ohio, United States, 44195
Principal Investigator:
Prashanti Thota, MD
Sponsor
Case Comprehensive Cancer Center
Last update posted
Sep 15, 2026
Last verified
Sep, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-26. This information was provided to ClinicalTrials.gov by Case Comprehensive Cancer Center on 2026-09-15. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.